0HAV Stock Overview Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. More details
Rewards Risk Analysis No risks detected for 0HAV from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Agilent Technologies, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Agilent Technologies Historical stock prices Current Share Price US$134.73 52 Week High US$155.01 52 Week Low US$122.20 Beta 1.06 1 Month Change 6.13% 3 Month Change -3.23% 1 Year Change -3.37% 3 Year Change -14.64% 5 Year Change 58.86% Change since IPO 80.07%
Recent News & Updates
Insufficient new directors Dec 01
Full year 2024 earnings released: EPS: US$4.45 (vs US$4.22 in FY 2023) Nov 26
Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025 Nov 26
Agilent Technologies, Inc. Increases Quarterly Cash Dividend, Payable on January 22, 2025 Nov 21
Agilent Technologies, Inc. Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research Nov 14
Agilent Technologies, Inc. to Report Q4, 2024 Results on Nov 25, 2024 Oct 17 See more updates
Insufficient new directors Dec 01
Full year 2024 earnings released: EPS: US$4.45 (vs US$4.22 in FY 2023) Nov 26
Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025 Nov 26
Agilent Technologies, Inc. Increases Quarterly Cash Dividend, Payable on January 22, 2025 Nov 21
Agilent Technologies, Inc. Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research Nov 14
Agilent Technologies, Inc. to Report Q4, 2024 Results on Nov 25, 2024 Oct 17
Third quarter dividend of US$0.24 announced Sep 22
Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 23, 2024 Sep 19
Third quarter 2024 earnings released: EPS: US$0.97 (vs US$0.38 in 3Q 2023) Aug 22
Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024 Aug 22
Agilent Technologies, Inc. Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance Aug 16
Now 20% undervalued after recent price drop Aug 05
Agilent Technologies, Inc. Receives FDA Approval for Mage-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy Aug 02
Agilent Technologies, Inc. (NYSE:A) acquired Sigsense Technologies, Inc. Jul 29
Agilent Technologies, Inc. Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit Jul 22
Agilent Technologies, Inc. to Report Q3, 2024 Results on Aug 21, 2024 Jul 17
Now 21% undervalued after recent price drop Jul 16
Now 23% undervalued after recent price drop Jul 05
Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index Jul 03
Now 23% undervalued after recent price drop Jul 03
Now 22% undervalued after recent price drop Jul 02
Now 22% undervalued after recent price drop Jul 02
Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary Jul 01
Now 21% undervalued after recent price drop Jul 01
Insider recently sold US$2.0m worth of stock Jun 13
Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics Jun 05 Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024
Second quarter 2024 earnings released: EPS: US$1.05 (vs US$1.02 in 2Q 2023) May 30
Now 20% undervalued May 29
First quarter dividend of US$0.24 announced May 26
Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors May 25 Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors
Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024 May 23
Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024 May 03
Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution May 01
Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024 Apr 30
Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics Apr 03
Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency Apr 02
First quarter dividend of US$0.24 announced Mar 20
Agilent Technologies, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024 Feb 29 Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024
Agilent Technologies, Inc. to Report Q1, 2024 Results on Feb 27, 2024 Jan 26
Agilent Technologies, Inc. Announces New Proteoanalyzer System Jan 16
Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024 Dec 23 Agilent Makes Strategic Updates to Organizational Structure Dec 21
Insider recently sold US$2.0m worth of stock Dec 20
Agilent Technologies Inc. Announces the Addition of Water Immersion and New Confocal Spinning Disk Technology to the Biotek Cytation C10 Confocal Imaging Reader Dec 04
Full year 2023 earnings released: EPS: US$4.22 (vs US$4.19 in FY 2022) Nov 21
Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Fiscal Year 2024 Nov 21
Agilent Technologies Inc. Increases Quarterly Cash Dividend, Payable on January 24, 2024 Nov 17
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Nov 15
Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group Nov 02
Now 21% undervalued after recent price drop Oct 25
Agilent Technologies, Inc. to Report Q4, 2023 Results on Nov 20, 2023 Oct 24
Agilent Technologies, Inc. Announces Quarter Dividend, Payable on October 25, 2023 Sep 21
Exact Sciences Corporation (NasdaqCM:EXAS) agreed to acquire Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A). Sep 13
Agilent Technologies, Inc. Announces Management Changes Sep 07
Agilent Technologies, Inc. Appoints Philip Binns as President of Life Sciences and Applied Markets Group Sep 06
New minor risk - Earnings quality Sep 01
Agilent Technologies, Inc. Provides Earnings Guidance for the Year 2023 Aug 17
Third quarter 2023 earnings released: EPS: US$0.38 (vs US$1.10 in 3Q 2022) Aug 16
Agilent Technologies, Inc. to Report Q3, 2023 Results on Aug 15, 2023 Jul 22
Agilent Technologies Inc. Announces the Launch of New Gen6 Software for All Agilent BioTek Detection Instruments Jul 11
Upcoming dividend of US$0.23 per share at 0.8% yield Jun 23
Agilent Technologies Inc. Introduces New Comprehensive GPC/SEC Solutions At HPLC 2023 Conference Jun 13
Agilent Announces Biotek 406 Fx Washer Dispenser for Technology-Driven Workflow Efficiency Jun 09
Agilent Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Full Year Ended 2023 May 24
Second quarter 2023 earnings released: EPS: US$1.02 (vs US$0.92 in 2Q 2022) May 24
Agilent Technologies, Inc. Announces Cash Dividend, Payable on July 26, 2023 May 18
Upcoming dividend of US$0.23 per share at 0.7% yield Mar 27
First quarter 2023 earnings released: EPS: US$1.19 (vs US$0.94 in 1Q 2022) Mar 01
Agilent Technologies Inc. Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance Feb 10
Agilent Technologies, Inc., Annual General Meeting, Mar 15, 2023 Feb 04
Agilent Technologies, Inc. to Report Q1, 2023 Results on Feb 28, 2023 Jan 31
Agilent Technologies, Inc. (NYSE:A) announces an Equity Buyback for $2,000 million worth of its shares. Jan 10
Agilent Technologies, Inc. (NYSE : A) acquired Avida Biomed Inc. Jan 05
Upcoming dividend of US$0.23 per share Dec 23
Full year 2022 earnings released: EPS: US$4.19 (vs US$3.98 in FY 2021) Dec 22
Insider recently sold US$4.6m worth of stock Dec 16
Agilent Technologies, Inc.'s ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer Dec 13
Independent Non-Executive Chairman recently sold US$2.0m worth of stock Dec 11
Principal Accounting Officer recently sold US$724k worth of stock Nov 29
Full year 2022 earnings released: EPS: US$4.19 (vs US$3.98 in FY 2021) Nov 22
Agilent Technologies, Inc. Provides Revenue Guidance for the First Quarter and Year Full Year 2023 Nov 22
Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on January 25, 2023 Nov 17
Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0 Nov 15
Agilent Technologies, Inc. to Report Q4, 2022 Results on Nov 21, 2022 Nov 02
Agilent Technologies Inc. Announces Release of its Enhanced 8700 LDIR Chemical Imaging System for Microplastics Analysis Oct 04
Insider recently sold US$258k worth of stock Oct 01
Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on October 26, 2022 Sep 22
Insider recently sold US$337k worth of stock Sep 10 Shareholder Returns 0HAV GB Life Sciences GB Market 7D -2.5% -8.8% -2.6% 1Y -3.4% -29.8% 2.7%
See full shareholder returns
Return vs Market: 0HAV underperformed the UK Market which returned 2.7% over the past year.
Price Volatility Is 0HAV's price volatile compared to industry and market? 0HAV volatility 0HAV Average Weekly Movement 3.8% Life Sciences Industry Average Movement 7.2% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.5% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0HAV has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0HAV's weekly volatility (4%) has been stable over the past year.
About the Company Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Show more Agilent Technologies, Inc. Fundamentals Summary How do Agilent Technologies's earnings and revenue compare to its market cap? 0HAV fundamental statistics Market cap US$37.98b Earnings (TTM ) US$1.29b Revenue (TTM ) US$6.51b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0HAV income statement (TTM ) Revenue US$6.51b Cost of Revenue US$2.98b Gross Profit US$3.54b Other Expenses US$2.25b Earnings US$1.29b
Last Reported Earnings
Oct 31, 2024
Earnings per share (EPS) 4.52 Gross Margin 54.30% Net Profit Margin 19.80% Debt/Equity Ratio 57.5%
How did 0HAV perform over the long term?
See historical performance and comparison Dividends
0.7% Current Dividend Yield When do you need to buy 0HAV by to receive an upcoming dividend? Agilent Technologies dividend dates Ex Dividend Date Dec 31 2024 Dividend Pay Date Jan 22 2025 Days until Ex dividend 10 days Days until Dividend pay date 32 days
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/20 18:21 End of Day Share Price 2024/12/20 00:00 Earnings 2024/10/31 Annual Earnings 2024/10/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Agilent Technologies, Inc. is covered by 43 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution James Francis Mainwaring Atlantic Equities LLP Catherine Ramsey Schulte Baird Ishan Majumdar Baptista Research
Show 40 more analysts 
